Skip to main content
. 2023 Feb 11;21:117. doi: 10.1186/s12967-023-03953-7

Table 1.

Baseline characteristics of patients before and after propensity score matching

No. of patients Before match After match
IBS (n = 365) Controls (n = 1157) p IBS (n = 354) Controls (n = 354) p
Age (median [IQR])† 45 [33, 59] 45 [35, 57] 0.407 45 [36, 57] 46 [35, 59] 0.610
BMI (median [IQR])† 23.67 [21.46, 25.80] 22.80 [20.94, 5.62] 0.027* 22.90 [20.97, 25.65] 23.03 [20.98, 25.48] 0.605
Country (n, %)  < 0.001* 1.000
 USA 175 (47.95) 832 (71.91) 175 (49.44) 175 (49.44)
 UK 169 (46.30) 274 (23.68) 160 (45.20) 160 (45.20)
 Australia 11 (3.01) 19 (1.64) 9 (2.54) 9 (2.54)
 Switzerland 6 (1.64) 12 (1.04) 6 (1.69) 6 (1.69)
 Canada 4 (1.10) 20 (1.73) 4 (1.13) 4 (1.13)
Sex (n, %)  < 0.001* 1.000
 Female 238 (65.21) 488 (42.18) 227 (64.12) 227 (64.12)
 Male 127 (34.79) 669 (57.82) 127 (35.88) 127 (35.88)

IBS irritable bowel syndrome, BMI body weight index

p value was derived from the Mann–Whitney test in data of continuous variables with abnormal distribution (M, Median; IQR, Interquartile Range). p value was derived from the Chi-square test or fisher’s exact test in data of categorical variables from IBS and healthy controls (n,%). *p < 0.05